SR8278
CAS No. 1254944-66-5
SR8278( —— )
Catalog No. M21127 CAS No. 1254944-66-5
SR8278 is an REV-ERBα antagonist(EC50 = 0.47 μM) blocking activation of the receptor by the synthetic agonist GSK 4112.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 112 | In Stock |
|
| 10MG | 177 | In Stock |
|
| 50MG | 414 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSR8278
-
NoteResearch use only, not for human use.
-
Brief DescriptionSR8278 is an REV-ERBα antagonist(EC50 = 0.47 μM) blocking activation of the receptor by the synthetic agonist GSK 4112.
-
DescriptionSR8278 is an REV-ERBα antagonist(EC50 = 0.47 μM) blocking activation of the receptor by the synthetic agonist GSK 4112.(In Vitro):SR8278 has REV-ERBα transcriptional repression inhibitory activity with an EC50 of 0.47μM.(In Vivo):SR8278 (slow microinjection; 20 μg/mouse) exerts antidepressant and anxiolytic effects in a circadian time-dependent manner in 6-OHDA-lesioned mice and restores the circadian rhythm of mood-related behaviors.SR8278 (slow microinjection; 20 μg/mouse) restores the binding activities of REV-ERBα and NURR1 to the tyrosine hydroxylase promoter and the induction of enrichment of the R/N motif, recognized by REV-ERBα and NURR1.
-
In VitroSR8278 has REV-ERBα transcriptional repression inhibitory activity with an EC50 of 0.47μM.
-
In VivoSR8278 (slow microinjection; 20 μg/mouse) exerts antidepressant and anxiolytic effects in a circadian time-dependent manner in 6-OHDA-lesioned mice and restores the circadian rhythm of mood-related behaviors. SR8278 (slow microinjection; 20 μg/mouse) restores the binding activities of REV-ERBα and NURR1 to the tyrosine hydroxylase promoter and the induction of enrichment of the R/N motif, recognized by REV-ERBα and NURR1. Animal Model:6-OHDA-lesioned mice Dosage:20 μg/mouse Administration:slow microinjection; 20 μg/mouse Result:Recovered mood-related behavioral deficits shown in 6-OHDA-lesioned mice. Altered remaining DAergic neuron specific transcription levels of REV-ERBα and Nurr1 in the VTA. Restored antagonistic crosstalk of REV-ERBα and NURR1 binding activity to TH promoter and TH protein levels in VTA. Induced enrichments of REV-ERBα and NURR1 binding motifs at dawn.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorREV-ERBα
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1254944-66-5
-
Formula Weight361.48
-
Molecular FormulaC18H19NO3S2
-
Purity>98% (HPLC)
-
SolubilityDMSO:10mg/ml(27.66mM)
-
SMILESCCOC(=O)C1Cc2ccccc2CN1C(=O)c1ccc(SC)s1
-
Chemical Nameethyl 2-{[5-(methylsulfanyl)thiophen-2-yl]carbonyl}-1234-tetrahydroisoquinoline-3-carboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kojetin D Wang Y Kamenecka T M et al. Identification of SR8278 a Synthetic Antagonist of the Nuclear Heme Receptor REV-ERB[J]. Acs Chemical Biology 2011 6(2):131-134.
molnova catalog
related products
-
CORT-108297 Enantiom...
CORT-108297 Enantiomer is an enantiomer of CORT-108297 which is an antagonist of the Glucocorticoid Receptor.
-
Ginsenoside F4
Ginsenoside F4 has inhibitory effect on human lymphocytoma JK cell by inducing its apoptosis, the mechanism is related to the mitochondrial dysfunction and the increase of Bax expression and decrease of Bcl-2 expression.
-
4-CPPC
4-CPPC is an inhibitor of macrophage migration inhibitory factor-2 (MIF-2; IC50= 27 μM).
Cart
sales@molnova.com